Cubist Systematic Strategies, LLC Io Biotech, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $20.3 Billion
- Q2 2025
A detailed history of Cubist Systematic Strategies, LLC transactions in Io Biotech, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 13,096 shares of IOBT stock, worth $23,048. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,096Holding current value
$23,048% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IOBT
# of Institutions
27Shares Held
18.2MCall Options Held
0Put Options Held
0-
Vivo Capital, LLC Palo Alto, CA6.17MShares$10.9 Million1.82% of portfolio
-
Novo Holdings Hellerup, G73.35MShares$5.9 Million0.41% of portfolio
-
Marshall Wace, LLP London, X02.11MShares$3.71 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA1.97MShares$3.47 Million0.26% of portfolio
-
Bank Of America Corp Charlotte, NC1.62MShares$2.84 Million0.0% of portfolio
About IO Biotech, Inc.
- Ticker IOBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,815,300
- Market Cap $50.7M
- Description
- IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...